Cutler Group’s DermTech, Inc. Common Stock DMTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-800
Closed -$1K 4341
2023
Q1
$1K Buy
+800
New +$3.37K ﹤0.01% 3640
2022
Q4
Sell
-5,400
Closed -$8K 5447
2022
Q3
$8K Buy
5,400
+5,200
+2,600% +$32K ﹤0.01% 3340
2022
Q2
$2K Sell
200
-1,300
-87% -$10.6K ﹤0.01% 4422
2022
Q1
$14K Sell
1,500
-2,500
-63% -$33.5K ﹤0.01% 3363
2021
Q4
$26K Sell
4,000
-8,800
-69% -$211K ﹤0.01% 2930
2021
Q3
$68K Buy
12,800
+5,100
+66% +$179K ﹤0.01% 2254
2021
Q2
$31K Sell
7,700
-5,200
-40% -$214K ﹤0.01% 2919
2021
Q1
$78K Buy
+12,900
New +$675K ﹤0.01% 1980

Other funds holding DMTK

Cutler Group's DMTK Position: Q4 2023 in Review

Cutler Group sold out of DermTech, Inc. Common Stock (DMTK) in Q4 2023, closing a stake of 494 shares — an estimated $721 sold.

Cutler Group first reported a position in DMTK in Q4 2020 and held it in 12 quarters. The position peaked at $845K in Q2 2021. 77 funds tracked by Wall St. Rank hold DMTK as of Q4 2023.

  • Cutler Group reported no remaining DermTech, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Cutler Group sold 494 DermTech, Inc. Common Stock shares in Q4 2023, an estimated $721.
  • Cutler Group first reported a position in DermTech, Inc. Common Stock in Q4 2020 and held it in 12 quarters.
  • Cutler Group's DermTech, Inc. Common Stock position peaked at $845K in Q2 2021.
  • 77 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q4 2023.

Based on Cutler Group's 13F filing for Q4 2023, filed 18 Jan 2024.